Fig. 1From: Activation of natural killer cells by rituximab in granulomatosis with polyangiitisSchematic overview of NK cell-mediated antibody-dependent cellular cytotoxicity (ADCC) induced by rituximab, as described previously in a non-malignant experimental setting [24]Back to article page